Quantcast

Daily Archives: February 4, 2008

Biogen-Idec Earnings Preview (BIIB, DNA)

Posted: February 4, 2008 at 6:31 pm

On Wednesday, we’ll get to see earnings out of Biogen Idec Inc. (NASDAQ: BIIB). The estimates from First Call for the biotech company are $0.80 EPS on $835.16 million in ...
Read Full Story »

SPAC IPO FILING: Corporate Acquirers Inc.

Posted: February 4, 2008 at 6:14 pm

Corporate Acquirers Inc., is a SPAC, or special purpose acquisition company, that submitted an IPO filing today. The filing shows $100 million proceeds targeted at $10.00 per unit, each unit ...
Read Full Story »

SPAC IPO FILING: K Road Acquisition Corp.

Posted: February 4, 2008 at 6:08 pm

K Road Acquisition Corporation, a SPAC, or special purpose acquisition company, submitted an IPO filing last Friday. The filing shows $300 million proceeds targeted at $10.00 per unit, each unit ...
Read Full Story »

Murdoch Grows Operating Income In 7 of 8 Segments (NWS)

Posted: February 4, 2008 at 5:00 pm

NEWS CORP (NYSE: NWS, NWS-A) has just posted earnings of $832 million or $0.27 EPS.  Its consolidated operating income for the second quarter was $1.4 billion was up 24% versus ...
Read Full Story »

The 52-Week Low Club (DTG)(SCMR)(VYYO)

Posted: February 4, 2008 at 4:45 pm

Dollar Thrifty Automotive (DTG) Rental car company stocks fall as DTG cuts outlook. Drops to $16.27 from 52-week high of $55.30.Ryanair Holdings (RYAAY) Airline warns of rough ride ahead. Sells ...
Read Full Story »

Rambus Earnings: Heads or Tails? (RMBS)

Posted: February 4, 2008 at 4:29 pm

Rambus Inc. (NASDAQ: RMBS) has just posted earnings with a net loss of 0$0.14 EPS on revenues of $40.5 million.  First Call had estimates of -$0.10 EPS and $40 million ...
Read Full Story »

Synchronoss Up On Results (SNCR)

Posted: February 4, 2008 at 4:19 pm

Synchronoss Technologies, Inc. (NASDAQ: SNCR) has just posted earnings of $0.22 EPS non-GAAP on revenues of $36.4 million.  First Call had estimates of $0.20 EPS and $35.65 million in revenues.  ...
Read Full Story »

Biotech News Day (February 4, 2008) (AMAG, AOB, AMGN, CELG, MNTA, OMRI, SVA, STEM)

Posted: February 4, 2008 at 2:41 pm

Below are some of the top issues affecting biotech shares today:AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), a biopharmaceutical company developing iron compounds to treat anemia, saw shares rise 4% to $56.00 ...
Read Full Story »

Can Barry Diller Even Focus on Earnings? (IACA, LINTA)

Posted: February 4, 2008 at 2:30 pm

On Wednesday morning, we’ll get to see earnings out of IAC/InterActiveCorp (NASDAQ: IACI).  Frankly, this one has more questions than answers today.  We do not know if Barry Diller is ...
Read Full Story »

Dumb Enough To Buy The Brooklyn Bridge

Posted: February 4, 2008 at 2:25 pm

Owning a toll bridge or a toll road would seem like a license to steal. It is, if you can get the asset at a good price.With real estate and ...
Read Full Story »

Akamai Technologies Earnings Preview (AKAM)

Posted: February 4, 2008 at 1:17 pm

On Wednesday after the close of trading, we’ll get to see earnings out of Akamai Technologies Inc. (NASDAQ: AKAM). The estimates from First Call for the internet content enhanced-delivery technology ...
Read Full Story »

Earnings Expectations From Disney (DIS)

Posted: February 4, 2008 at 12:20 pm

On Tuesday, we’ll get to see earnings out of Walt Disney Co. (NYSE:DIS). The estimates from First Call for the entertainment giant are $0.52 EPS on $10.04 billion in revenues.  ...
Read Full Story »

What To Expect From Boston Scientific Earnings (BSX)

Posted: February 4, 2008 at 11:46 am

On Tuesday morning, we’ll get to see earnings out of Boston Scientific Corp. (NYSE:BSX). The estimates from First Call for the medical device developer are $0.09 EPS on $2.13 billion ...
Read Full Story »

Itron: Lazard Still Looking For New Highs (ITRI)

Posted: February 4, 2008 at 11:19 am

Itron Inc. (NYSE: ITRI) shares are being given a positive note this morning.  Analyst Sanjay Shrestha of Lazard Capital Markets is maintaining his Buy rating and $115.00 target.  This number ...
Read Full Story »

AmTech Removing Intel From Focus List (INTC)

Posted: February 4, 2008 at 9:50 am

American Technology Research is removing Intel (NASDAQ: INTC) from its FOCUS LIST this morning.  AmTech is still maintaining its  official Buy rating and its $27.00 price target on the stock ...
Read Full Story »